130 related articles for article (PubMed ID: 37067389)
21. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
[TBL] [Abstract][Full Text] [Related]
23. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
[TBL] [Abstract][Full Text] [Related]
24. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
25. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
26. Management of arteriovenous malformations: a multidisciplinary approach.
Lee BB; Do YS; Yakes W; Kim DI; Mattassi R; Hyon WS
J Vasc Surg; 2004 Mar; 39(3):590-600. PubMed ID: 14981454
[TBL] [Abstract][Full Text] [Related]
27. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
28. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.
Sabri SS; Swee W; Turba UC; Saad WE; Park AW; Al-Osaimi AM; Caldwell SH; Matsumoto AH; Angle JF
J Vasc Interv Radiol; 2011 Mar; 22(3):309-16; quiz 316. PubMed ID: 21353984
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
30. Sclerotherapy in venous malformation.
Rabe E; Pannier F
Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
[TBL] [Abstract][Full Text] [Related]
31. Efficiency and safety of ethanol sclerotherapy for labial arteriovenous malformations.
Qu ZY; Yang B; Yang FY; Liao ZY
J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):713-720.e1. PubMed ID: 34774812
[TBL] [Abstract][Full Text] [Related]
32. Implication of foam sclerosant inactivation by human whole blood in a laboratory setting.
Dabbs EB; Dos Santos SJ; Mainsiouw LE; Sheikh AA; Gkantiragas A; Shiangoli I; Watkins MR; Nemchand JL; Whiteley MS
Phlebology; 2018 Jun; 33(5):338-343. PubMed ID: 28516808
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
[TBL] [Abstract][Full Text] [Related]
34. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
[TBL] [Abstract][Full Text] [Related]
35. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
[TBL] [Abstract][Full Text] [Related]
37. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
Watkins MR; Oliver RJ
Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of transarterial bleomycin sclerotherapy of early-stage facial arteriovenous malformation: Single-center multidisciplinary team experience.
Lee SY; Kang DH; Kim YS; Lee J; Lee SJ; Huh S; Kim JY; Chung HY
J Plast Reconstr Aesthet Surg; 2023 Feb; 77():379-387. PubMed ID: 36623374
[TBL] [Abstract][Full Text] [Related]
39. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.
O'Donovan JC; Donaldson JS; Morello FP; Pensler JM; Vogelzang RL; Bauer B
AJR Am J Roentgenol; 1997 Sep; 169(3):723-9. PubMed ID: 9275886
[TBL] [Abstract][Full Text] [Related]
40. A 6-year experience treating vascular malformations with foam sclerotherapy.
Markovic JN; Kim CY; Lidsky ME; Shortell CK
Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
